QDEL:NASDAQ
Quidelortho Corp
US$13,79
arrow_upward
+2,00%(+0,27) 1D
26 ມິ.ຖ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for QDEL...
Open
US$13,53
High
US$14,17
Low
US$13,52
Mkt. cap
໙໔໐,໓໕ ລ້ານ
Avg. vol.
໑,໗໔ ລ້ານ
Volume
໙,໐໐
52-wk high
US$35,58
52-wk low
US$9,92
EPS
US$-17,82
Beta
໐,໗໗
Shares outstanding
໖໘,໑໙ ລ້ານ
No. of employees
໖ ພັນ
Open
US$13,53
High
US$14,17
Low
US$13,52
Mkt. cap
໙໔໐,໓໕ ລ້ານ
Avg. vol.
໑,໗໔ ລ້ານ
Volume
໙,໐໐
52-wk high
US$35,58
52-wk low
US$9,92
EPS
US$-17,82
Beta
໐,໗໗
Shares outstanding
໖໘,໑໙ ລ້ານ
No. of employees
໖ ພັນ
News stories
From sources across the web
www.marketscreener.com
·
7 ຊົ່ວໂມງກ່ອນ
QuidelOrtho Corporation(NasdaqGS: QDEL) dropped from Russell 3000 Growth Benchmark
Financial Times
·
1 ມື້ກ່ອນ
QuidelOrtho looks to sell testing unit as PE circles healthcare companies
Profile
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs. Wikipedia
About Quidelortho Corp
CEODouglas C Bryant
Employees6,5 ພັນ
Founded1979
Headquartersແຊນ ດີເອໂກ, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorMedical device
Websitequidelortho.com
AI content may include mistakes. Learn more